Mosaic ImmunoEngineering Inc.
CPMV · OTC
12/31/2024 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | – |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | – |
| Gross Profit | $0 | $0 | $0 | – |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $1 | $1 | – |
| G&A Expenses | $1 | $2 | $2 | – |
| SG&A Expenses | $1 | $2 | $2 | – |
| Sales & Mktg Exp. | $0 | $0 | $0 | – |
| Other Operating Expenses | $0 | $0 | $0 | – |
| Operating Expenses | $1 | $3 | $4 | – |
| Operating Income | -$1 | -$3 | -$4 | – |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$0 | $0 | -$0 | – |
| Pre-Tax Income | -$1 | -$2 | -$4 | – |
| Tax Expense | $0 | $0 | $0 | – |
| Net Income | -$1 | -$2 | -$4 | – |
| % Margin | – | – | – | – |
| EPS | -0.13 | -0.33 | -0.55 | – |
| % Growth | 60.6% | 40% | – | – |
| EPS Diluted | -0.13 | -0.33 | -0.55 | – |
| Weighted Avg Shares Out | 7 | 7 | 7 | – |
| Weighted Avg Shares Out Dil | 7 | 7 | 7 | – |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | – |
| Interest Expense | $0 | $0 | $0 | – |
| Depreciation & Amortization | $1 | $0 | $0 | – |
| EBITDA | -$1 | -$2 | -$4 | – |
| % Margin | – | – | – | – |